By the end of this course, participants should be able to:
- Understand the scientific basis for cell-based therapies
- Describe new data regarding the capacity of specific cell lineages for cardiac repair
- Be familiar with results of clinical studies and the status of large-scale efficacy trials
- Appreciate the developmental strategies of next-generation cells, engineered tissue, and their expected first-in-human uses
- Appreciate the status of cardiovascular stem cell science at the global level, including development of resources, industry activities, strategies for collaboration, and current applicable policies
This conference is designed for clinicians and clinical investigators, interventional cardiologists, noninvasive cardiologists, cardiac surgeons, research associates, basic science investigators (cell and molecular biologists), members of public and private funding organizations, hospital administrators, program directors, legislators, and regulatory agency personnel.
Online evaluation will address content, presentation, possible bias, and future educational needs.
Please note that the Ninth International Conference on Cell Therapy for Cardiovascular Disease is not CME-accredited. Certificates of Attendance will be available on-site in exchange for a completed course evaluation.
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
Program Sponsorship and Support
This activity is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from commercial supporters.
What People Are Saying About the Cell Therapy Conference…
Congratulations for such terrific meeting and many thanks for the opportunity. Was a great pleasure and honor to participate.
Francisco F. Avilés, MD, PhD
Congratulations for this great meeting and thank you for the opportunity of presenting. It really was a great pleasure to participate.
Stephen Ellis, MD
Thank you for organizing such a great meeting!
Thomas Ichim, MD